McKesson Corporation
General ticker "MCK" information:
- Sector: Health Care
- Industry: Medical - Distribution
- Capitalization: $97.2B (TTM average)
McKesson Corporation follows the US Stock Market performance with the rate: 18.7%.
Estimated limits based on current volatility of 1.2%: low 725.38$, high 742.77$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-03-02, amount 0.82$ (Y0.44%)
- Total employees count: 43000 (-4.4%) as of 2026
- Top business risk factors: Regulatory and compliance, Cybersecurity threats, Acquisition/divestiture risks, Customer concentration, Healthcare reform
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-03-31 to 2028-03-30
- 2026-03-31 to 2027-03-31 estimated range: [697.24$, 970.56$]
- 2027-03-31 to 2028-03-30 estimated range: [765.34$, 1056.75$]
Financial Metrics affecting the MCK estimates:
- Negative: with PPE of 22.5 at the end of fiscal year the price was high
- Positive: -5.39 < Operating profit margin, % of 1.54
- Positive: 1.81 < Return on assets ratio (scaled to [-100,100]) of 5.83
- Positive: Interest expense per share per price, % of 0.23 <= 0.73
- Positive: Inventory ratio change, % of -0.36 <= 0
- Negative: Shareholder equity ratio, % of -2.64 <= 19.24
- Positive: 0.05 < Industry earnings per price (median), % of 3.52
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 4.84
- Negative: Investing cash flow per share per price, % of -3.16 <= -0.60
Short-term MCK quotes
Relationship graph
Long-term MCK plot with estimates
Financial data
| YTD | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|
| Operating Revenue | $308,804.00MM | $358,943.00MM | $403,433.00MM |
| Operating Expenses | $304,895.00MM | $354,521.00MM | $397,221.00MM |
| Operating Income | $3,909.00MM | $4,422.00MM | $6,212.00MM |
| Non-Operating Income | $-120.00MM | $-63.00MM | $-11.00MM |
| Interest Expense | $252.00MM | $265.00MM | $247.00MM |
| Income(Loss) | $3,789.00MM | $4,359.00MM | $6,201.00MM |
| Taxes | $629.00MM | $878.00MM | $1,102.00MM |
| Net Income(Loss)* | $3,002.00MM | $3,295.00MM | $4,762.00MM |
| Stockholders Equity | $-1,971.00MM | $-2,074.00MM | $-2,172.00MM |
| Inventory | $21,139.00MM | $23,001.00MM | $24,207.00MM |
| Assets | $67,443.00MM | $75,140.00MM | $82,323.00MM |
| Operating Cash Flow | $4,314.00MM | $6,085.00MM | $6,155.00MM |
| Capital expenditure | $687.00MM | $859.00MM | $436.00MM |
| Investing Cash Flow | $-1,072.00MM | $-733.00MM | $-3,432.00MM |
| Financing Cash Flow | $-3,342.00MM | $-3,965.00MM | $-4,631.00MM |
| Earnings Per Share** | $22.54 | $25.86 | $38.53 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.